Feedback / Questions
arsenic trioxide oral (QTX-2101) - Quetzal Therapeutics
https://www.globenewswire.com/news-release/2025/12/02/3198337/0/en/Quetzal-Therapeutics-Launches-Phase-III-Clinical-Trial-of-Oral-QTX-2101-for-Acute-Promyelocytic-Leukemia-APL.html
 
Dec 2, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious